How long can GLP-1s stay out of the fridge? Every labeled window, sourced

Room-temperature windows are the most misquoted numbers in the GLP-1 supply chain — rounded, swapped between products, and quietly repurposed as an excuse for warm shipping. This page exists so you can stop citing a forum post. Each row below was checked against the current label.

The GLP-1 windows, product by product

One footnote for tirzepatide: Mounjaro’s multi-dose vial and single-patient-use KwikPen presentations carry their own 30-day limits — unopened product stored at room temperature must be discarded after 30 days, and opened product after 30 days or four weekly doses (Eli Lilly prescribing information, 2026). If your operation touches those presentations, read that label separately; the 21-day figure above is for single-dose pens and vials.

Read the clock language, not just the number

The labels differ in what starts and stops the clock, and the differences are operationally significant:

• “A total of” means cumulative. Mounjaro’s label instructs discarding the single-dose pen or vial “after a total of 21 days at room temperature” (Eli Lilly, 2026). Zepbound and Trulicity use the same construction. Hours out of the refrigerator add up across every episode — putting the pen back in the fridge parks the clock but does not rewind it.
• Wegovy’s window runs before use, not after. The single-dose pen “can be kept from 8°C to 30°C up to 28 days” prior to cap removal (Novo Nordisk, 2026). It is an allowance for a pen awaiting its one injection — not an in-use period.
• Ozempic’s 56 days is total in-use life. After first use the pen may be kept at 15–30°C or refrigerated, and it expires 56 days after first use either way (Novo Nordisk, 2026). Refrigeration does not extend it.

Freezing voids every window

No room-temperature allowance survives a trip below the freeze line. Wegovy: “Do not freeze Wegovy and do not use if it has been frozen.” Mounjaro: “Do not use Mounjaro if frozen.” Zepbound’s labeling instructs discarding frozen product; so does Trulicity’s. Novo Nordisk’s storage guidance for Ozempic disqualifies pens exposed below 36°F (2°C). These are unconditional discard instructions — and since a frozen-and-thawed pen looks normal, the only reliable witness is a temperature record. Winter mechanics are covered in the freeze problem.

Why shippers may not borrow these windows

Here is the misreading this page most wants to kill: “Ozempic is good for 56 days at room temperature, so two warm days in a truck is nothing.”

The window is an in-use allowance for the patient. It begins at first use, it exists so a patient can travel and keep a pen in a bathroom cabinet, and it is backed by the sponsor’s stability program for exactly that scenario. Product in a parcel network is unopened, and unopened product is held to its storage labeling: refrigerate at 2–8°C. What transit gets instead is the USP <659> controlled cold envelope — excursions between 2°C and 15°C, not exceeding 24 hours, with mean kinetic temperature at or below 8°C (USP <659>). That is the standard a shipment is adjudicated against, and it is dramatically tighter than any label window. The chapter mechanics are in the transit temperature standard; the MKT arithmetic for a warm arrival is in adjudicating an excursion.

A pharmacy that knowingly spends label windows in transit is also making a quiet inventory decision on the patient’s behalf — handing over product whose labeled life started in a sort facility. Nothing in the labeling supports that, and no board of pharmacy has blessed it.

The insulin comparison: same refrigerator, different clocks

Insulin labels make the product-specificity point even more sharply, because the class has decades of them:

Three basal insulins, one storage class, windows from 28 to 56 days — and two of them prohibit refrigerating the pen once it is in use. Anyone claiming a universal rule for “refrigerated injectables” has not read three labels in a row. The window is formulation chemistry plus presentation plus the sponsor’s stability data, product by product.

Compounded GLP-1s: none of the above

Compounded semaglutide and tirzepatide inherit no window from any table on this page. The allowances above are conclusions from each sponsor’s stability program, run on its formulation, in its container. A compounded preparation is a different formulation in a different container from a different process — and under USP <659>’s framing, the compounding pharmacy is the manufacturer whose instructions and data govern. Unless your pharmacy has generated stability data supporting a room-temperature period for its own preparation, that preparation has no such period. Its beyond-use dating and storage assignment are on you, and your shipping SOP has to deliver the refrigerated condition end to end.